← Eichor
Condition: Antipsychotic Drug Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antipsychotic Drug

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CL
Phase 3 · 1 location(s) · Ain Shams University · NCT06936137Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968"Extended" (Alternate Day) Antipsychotic Dosing
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT04478838Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia
Phase 2/Phase 3 · 1 location(s) · Md. Moktadirul Hoque Shuvo · NCT07008235Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Sympt
Phase 3 · 13 location(s) · Minerva Neurosciences · NCT07565428Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses
NA · 2 location(s) · Centre Hospitalier St Anne · NCT06613334Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Phase 4 · 1 location(s) · University Hospitals Cleveland Medical Center · NCT06997198Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619National Pregnancy Registry for Psychiatric Medications
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT01246765No Guts No Glory Probiotics
Phase 2/Phase 3 · 3 location(s) · University Medical Center Groningen · NCT07606014AP Metabolism Transcriptomics
Phase N/A · 1 location(s) · IRCCS Eugenio Medea · NCT06814314Maternal And Infant Antipsychotic Study
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06049953Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
NA · 7 location(s) · Air Force Military Medical University, China · NCT06756139Effects of Antipsychotics on Brain Insulin Action in Females
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT06251635Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT05744479The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receivi
NA · 1 location(s) · DINA KEUMALA SARI · NCT07696000Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Phase 2 · 2 location(s) · New York State Psychiatric Institute · NCT05999240Norwegian Mental Illness Heart Health Study
NA · 1 location(s) · Madeleine Elisabeth Angelsen · NCT07085923Sex, Psychopharmacology, and Diabetes
NA · 1 location(s) · Zealand University Hospital · NCT05951660Comparing Antipsychotic Medications in LBD Over Time
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05590637Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polyphar
NA · 3 location(s) · Ludwig-Maximilians - University of Munich · NCT05842928Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic
NA · 1 location(s) · Bjorn H. Ebdrup · NCT06624462Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3 · 13 location(s) · LB Pharmaceuticals Inc. · NCT07363577Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Phase 4 · 1 location(s) · Northwell Health · NCT07483294Exercise and Olanzapine-samidorphan
Phase 4 · 1 location(s) · New York State Psychiatric Institute · NCT06740890CLOZAPINE Response in Biotype-1
Phase 4 · 5 location(s) · University of Texas Southwestern Medical Center · NCT04580134A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction
NA · 2 location(s) · University College Cork · NCT06729671Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT05748990
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.